Clinical Trials · NCT03689374
A Research Study to Compare Semaglutide to Insulin Aspart, When Taken Together With Metformin and Insulin Glargine, in People With Type 2 Diabetes
- Phase
- Phase 3
- Recruitment status
- Completed
- Sponsor
- Novo Nordisk A/S
- Enrollment
- 2,274
- Start date
- Oct 2018
- Locations
- 210 sites, 21 countries
- Primary endpoint
- Change From Baseline in Glycated Haemoglobin (HbA1c)